CAP en Español
Small CAP Banner

U.S. Stem Cell Ruling Invites Asian Competition

  • print icon
  • SHARE:
  • Facebook icon
  • Twitter icon
  • Share on Google+
  • Email icon

The ink had barely dried on last week’s U.S. court decision barring the National Institutes of Health from funding embryonic stem cell grants when I received this message from the second annual Stem Cells Asia Regenerative Medicine Congress, which meets in Seoul on October 26 through 28:

"Dear Jonathan Moreno,

—‰’Halt to U.S. Stem Cell Funding May Thwart Search for New Cures’ — Bloomberg News

"This is one of the most pertinent reasons why stakeholders of the stem cells arena are now moving to Asia to leverage on Asia’s laissez-faire regulations and capitalize on Asia’s growth potential in stem cell research and application."

And I was in fact quoted in that Bloomberg News story as follows:

"This is a catastrophe. "…It’s now possible that the United States is now taken out of embryonic stem cell research."

Read more here.

This article was originally published in San Jose Mercury.

To speak with our experts on this topic, please contact:

Print: Liz Bartolomeo (poverty, health care)
202.481.8151 or

Print: Tom Caiazza (foreign policy, energy and environment, LGBT issues, gun-violence prevention)
202.481.7141 or

Print: Allison Preiss (economy, education)
202.478.6331 or

Print: Tanya Arditi (immigration, Progress 2050, race issues, demographics, criminal justice, Legal Progress)
202.741.6258 or

Print: Chelsea Kiene (women's issues,, faith)
202.478.5328 or

Print: Elise Shulman (oceans)
202.796.9705 or

Print: Benton Strong (Center for American Progress Action Fund)
202.481.8142 or

Spanish-language and ethnic media: Jennifer Molina
202.796.9706 or

TV: Rachel Rosen
202.483.2675 or

Radio: Chelsea Kiene
202.478.5328 or